Market Overview

Global Drug Delivery in Cancer to 2027 - Focus on Technologies, Markets and Companies - ResearchAndMarkets.com

Share:

The "Drug
Delivery in Cancer - Technologies, Markets and Companies"

report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's
offering.

Innovative cancer therapies are based on current concepts of molecular
biology of cancer. These include antiangiogenic agents, immunotherapy,
bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases
and tyrosine kinase receptors, antisense approaches, gene therapy and
combination of various methods. Important methods of immunotherapy in
cancer involve use of cytokines, monoclonal antibodies, cancer vaccines
and immunogene therapy.

Several innovative methods of drug delivery are used in cancer. These
include use of microparticles as carriers of anticancer agents. These
may be injected into the arterial circulation and guided to the tumor by
magnetic field for targeted drug delivery. Polyethylene glycol (PEG)
technology has been used to overcome some of the barriers to anticancer
drug delivery. Encapsulating anticancer drugs in liposomes enables
targeted drug delivery to tumor tissues and prevents damage to the
normal surrounding tissues. Monoclonal antibodies can be used for the
delivery of anticancer payloads such as radionucleotides, toxins and
chemotherapeutic agents to the tumors.

Drug delivery strategies vary according to the type and location of
cancer. Role of drug delivery in the management of cancers of the brain,
the bladder, the breast, the ovaries and the prostate are used as
examples to illustrate different approaches both experimental and
clinical. Biodegradable implants of carmustine are already used in the
treatment of malignant brain tumors.

The market value of drug delivery technologies and the anticancer drugs
are difficult to separate. Cancer market estimates from 2017-2027 are
given according to organs involved and the types of cancer as well as
according to technologies. Distribution of the into major regions is
also described.

Profiles of 237 companies involved in developing innovative cancer
therapies and methods of delivery are presented along with their 284
collaborations. The bibliography contains over 650 publications that are
cited in the report.The report is supplemented with 65 tables and 17
figures.

Key Topics Covered:

Part I: Technologies & Markets

Executive Summary

1. Introduction to cancer therapy

2. Innovative treatments for cancer

3. Drug delivery systems for cancer

4. Delivery of Biological Therapies for Cancer

5. Delivery strategies according to cancer type and location

6. Cancer drug delivery markets

7. References

Part II: Companies

8. Companies involved in cancer drug delivery

For more information about this report visit https://www.researchandmarkets.com/research/7v2fq4/global_drug?w=4

View Comments and Join the Discussion!